Broad versus narrow clinical practice guidelines: avoiding rules for the high risk 1%

Vishnu Harikumar, Brandon Worley, Sarah A. Ibrahim, Bianca Y. Kang, Ian A. Maher, Todd V. Cartee, Joseph F. Sobanko, Nour Kibbi, Joshua L. Owen, Kelly A. Reynolds, Diana Bolotin, Abigail H. Waldman, Kira Minkis, Brian Petersen, M. Laurin Council, Kishwer S. Nehal, Y. Gloria Xu, S. Brian Jiang, Ally Khan Somani, Conway C. HuangDaniel B. Eisen, David M. Ozog, Erica H. Lee, Faramarz H. Samie, Isaac M. Neuhaus, Justin J. Leitenberger, Margaret W. Mann, Naomi Lawrence, Nathalie C. Zeitouni, Nicholas Golda, Ramona Behshad, Sherrif F. Ibrahim, Siegrid S. Yu, Thuzar M. Shin, William G. Stebbins, Murad Alam

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
JournalArchives of Dermatological Research
DOIs
StateAccepted/In press - 2020

Keywords

  • Cancer
  • Clinical Practice
  • Evidence-based medicine
  • Guidelines
  • High Risk

ASJC Scopus subject areas

  • Dermatology

Cite this